Key result
Adult Ross procedure linked to general-population survival and ~1% 12-year autograft reintervention.
Why the study?
What are the long-term clinical and echocardiographic outcomes of the Ross procedure in adults?
Cohort (n=455)
No
What are the long-term clinical and echocardiographic outcomes of the Ross procedure in adults?
Answers are grounded in this paper and cite their sources.
In a contemporary adult cohort, the Ross procedure demonstrated excellent long-term survival comparable to the general population and very low rates of reintervention at 12 years.
BACKGROUND: With renewed enthusiasm for the Ross procedure in adults in recent years, long-term data using contemporary techniques are needed. OBJECTIVES: The purpose of this study was to evaluate long-term clinical and echocardiographic outcomes of the Ross procedure in a contemporary adult cohort. METHODS: From 2011 to 2019, 455 consecutive adults (mean age 47 ± 12 years; 73% male) underwent a Ross procedure at a single high-volume tertiary center. This includes our inaugural experience with the procedure. All patients were prospectively followed with systematic clinical and echocardiographic follow-up. Outcomes included operative safety, long-term survival, reinterventions, valve hemodynamics, and autograft root dimensions. Median follow-up was 9.0 years (Q1-Q3: 7.3-11.1 years), with 98% completeness of clinical and echocardiographic follow-up (4,191 patient-years and 2,921 echocardiograms). RESULTS: Operative mortality was 0.4% (n = 2). No patient-prosthesis mismatch occurred, and permanent pacemaker implantation was required in 0.8% (n = 3). At 12 years, actuarial survival was comparable to the age- and sex-matched general population. The cumulative incidence of autograft reintervention at 12 years was 1.1% ± 0.5%, with no difference between patients with preoperative aortic regurgitation and aortic stenosis (1.2% ± 1.2% vs 1.1% ± 0.6%; P = 0.39, respectively). The cumulative incidence of pulmonary homograft reintervention at 12 years was 1.9% ± 0.9%, and any cardiac reintervention was 3.5% ± 1.0% at 12 years. Mean aortic valve gradient at 12 years was 4.0 ± 0.2 mm Hg. CONCLUSIONS: In a large contemporary adult cohort with comprehensive follow-up, the Ross procedure was associated with excellent long-term survival, durable valve performance, and low reintervention rates, including in patients with preoperative aortic regurgitation and those >50 years of age. These findings provide an important contemporary benchmark and support broader consideration of the Ross procedure in appropriately selected adults in experienced centers.
No takes yet. Share an insight, caveat, or question.
El-Hamamsy et al. (2026) conducted a cohort in Aortic valve disease (n=455). Ross procedure was evaluated on Autograft reintervention at 12 years. The Ross procedure in adults was associated with 0.4% operative mortality, survival comparable to the general population, and a 1.1% cumulative incidence of autograft reintervention at 12 years.
Synapse has enriched 10 related papers. Consider them for comparative context: